Priority Date: 25.10.11 (JP 20110233965)

HETEROCYCLE DERIVATIVE HAVING PGD2 RECEPTOR ANTAGONIST ACTIVITY

  • Application ID: EP12844230
  • Status: PATENT GRANTED

Attorney

Employment test 51 - 200 employees
Company dna boult wade tennant ltd
operating since 1894
Headquarter in London and 5 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 227 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 25.10.2011 - Priority Date (JP 20110233965)
  • 02.05.2013 - Publication A1 (WO2013061977)
  • 09.07.2014 - Publication A1 (EP2752410)
  • 31.08.2016 - Publication B1 (EP2752410)